Watch out, Pfiz­er and Mod­er­na; An­ti-ag­ing break­through in mice?; Neu­ro for the new GSK; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

The End­points team will be en­joy­ing a long week­end in ob­ser­vance of In­de­pen­dence Day on Mon­day. If you’re ded­i­cat­ed enough to be read­ing this re­port, don’t miss my col­league Zachary Bren­nan’s ex­cel­lent vir­tu­al event — a fire­side chat fol­lowed by a pan­el — on the post-Covid FDA. You can watch it on-de­mand here.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER